1. Home
  2. AMPH vs CAC Comparison

AMPH vs CAC Comparison

Compare AMPH & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$23.59

Market Cap

885.4M

Sector

Health Care

ML Signal

HOLD

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$57.67

Market Cap

923.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
CAC
Founded
1996
1875
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
885.4M
923.2M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
AMPH
CAC
Price
$23.59
$57.67
Analyst Decision
Buy
Buy
Analyst Count
8
2
Target Price
$28.38
$47.00
AVG Volume (30 Days)
326.4K
72.4K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
3.51%
EPS Growth
N/A
6.08
EPS
0.81
2.64
Revenue
$719,887,000.00
$41,739,000.00
Revenue This Year
$6.90
$19.15
Revenue Next Year
$4.64
$6.05
P/E Ratio
$28.44
$21.66
Revenue Growth
N/A
16.96
52 Week Low
$16.65
$35.00
52 Week High
$29.52
$60.59

Technical Indicators

Market Signals
Indicator
AMPH
CAC
Relative Strength Index (RSI) 66.77 51.63
Support Level $18.36 $56.91
Resistance Level $24.35 $60.07
Average True Range (ATR) 0.69 2.35
MACD 0.06 -0.05
Stochastic Oscillator 81.95 64.44

Price Performance

Historical Comparison
AMPH
CAC

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

Share on Social Networks: